Teleflex Inc header image

Teleflex Inc

TFX

Equity

ISIN US8793691069 / Valor 976212

New York Stock Exchange, Inc (2024-11-21)
USD 190.64+1.71%

Teleflex Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Teleflex Inc is a global company specializing in medical technologies aimed at enhancing the health and well-being of individuals. With a diverse portfolio of solutions in areas such as vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine, and respiratory care, Teleflex focuses on purpose-driven innovation to address unmet clinical needs and improve patient outcomes. With over 14,000 employees worldwide, the company is committed to making a difference in the healthcare industry through its innovative products and services.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Revenue Growth

Teleflex Inc. reported revenues of $773.9 million for the fourth quarter of 2023, reflecting a 2.1% increase compared to the same period in the prior year. On a constant currency basis, the revenue growth was 0.7%. This growth was achieved despite having five fewer shipping days year-over-year.

EPS Performance

For the fourth quarter of 2023, Teleflex Inc. reported GAAP diluted earnings per share (EPS) from continuing operations of $0.66, a significant decrease from $1.65 in the prior year period. Adjusted diluted EPS from continuing operations was $3.38, compared to $3.52 in the same period last year.

Full Year Financials

Teleflex Inc. achieved full-year 2023 revenues of $2,974.5 million, marking a 6.6% increase year-over-year. On a constant currency basis, the revenue growth was 6.5%. The company reported GAAP diluted EPS from continuing operations of $7.56, slightly down from $7.67 in the previous year, while adjusted diluted EPS from continuing operations rose to $13.52 from $13.06.

2024 Guidance

For the full year 2024, Teleflex Inc. has provided a GAAP revenue growth guidance range of 3.60% to 4.60%. On a constant currency basis, the revenue growth guidance range is 3.75% to 4.75%. The company expects GAAP EPS from continuing operations to be between $5.69 and $6.09, and adjusted diluted EPS from continuing operations to range from $13.55 to $13.95.

Segment Performance

In the fourth quarter of 2023, Teleflex Inc.'s Americas segment reported revenues of $450.6 million, a 1.6% decrease year-over-year. The EMEA segment saw a 3.1% increase to $152.4 million, while the Asia segment experienced a significant 12.5% growth to $88.3 million. The OEM segment also performed well, with revenues increasing by 12.1% to $82.6 million.

Summarized from source with an LLMView Source

Key figures

-12.0%1Y
-40.2%3Y
-45.7%5Y

Performance

29.9%1Y
31.8%3Y
33.9%5Y

Volatility

Market cap

8854 M

Market cap (USD)

Daily traded volume (Shares)

97,366

Daily traded volume (Shares)

1 day high/low

191.12 / 187.63

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Oncopeptides AB
Oncopeptides AB Oncopeptides AB Valor: 35671972
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.48%SEK 1.51
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.09%USD 37.89
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc Zimmer Biomet Holdings Inc Valor: 1262932
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.80%USD 108.40
dentalcorp Holdings Ltd
dentalcorp Holdings Ltd dentalcorp Holdings Ltd Valor: 111405816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.18%CAD 9.24
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.11%CHF 28.90
Savaria Corp
Savaria Corp Savaria Corp Valor: 1385257
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.80%CAD 22.81
Sienna Senior Living Inc
Sienna Senior Living Inc Sienna Senior Living Inc Valor: 28093100
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.24%CAD 17.03
WELL Health Technologies Corp
WELL Health Technologies Corp WELL Health Technologies Corp Valor: 42769021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.58%CAD 5.17
agilon health inc
agilon health inc agilon health inc Valor: 110653729
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.59%USD 1.78
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.61%EUR 9.80